Predictors of discontinuation include housing instability and prior history of PrEP discontinuation
THURSDAY, March 14, 2024 (HealthDay News) — Among sexual and gender-minority people who initiate preexposure prophylaxis (PrEP) for HIV, the annual rate of discontinuation is between 35 and 40 percent, according to a study published in the March issue of Health Affairs.
Yan Guo, Ph.D., from the City University of New York in New York City, and colleagues examined PrEP discontinuation among sexual and gender-minority individuals who initiated PrEP in a four-year national cohort study.
The researchers found that the annual rate of discontinuation was high (35 to 40 percent) after initiation of PrEP. In a multivariable analysis including 6,410 person-years, housing instability and a prior history of PrEP discontinuation were identified as predictors of discontinuation. Older age, clinical indication for PrEP, and having health insurance were associated with sustained use of PrEP.
“Urgent action is needed to improve PrEP initiation, adherence, and long-term retention in care,” the authors write. “PrEP implementation programs and providers of PrEP care should simultaneously assess for risk factors of PrEP discontinuation, including prior history of PrEP discontinuation, social determinants of health (for example, housing instability and lack of health insurance), and younger age.”
Abstract/Full Text (subscription or payment may be required)
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer